AI Verdict
LCTX has stronger fundamentals based on our AI analysis.
LCTX vs LCNB Fundamental Comparison
| Metric | LCTX | LCNB |
|---|---|---|
| Revenue | $14.6M | $102.7M |
| Net Income | $-63.5M | $23.1M |
| Net Margin | -436.5% | 22.5% |
| ROE | -142.6% | 8.4% |
| ROA | -56.4% | 1.0% |
| Current Ratio | 5.20x | N/A |
| Debt/Equity | 0.00x | 0.38x |
| EPS | $-0.28 | $1.63 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LCTX vs LCNB: Frequently Asked Questions
Is LCTX or LCNB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LCTX has stronger fundamentals. LCTX is rated SELL (88% confidence) while LCNB is rated SELL (72% confidence). This is not investment advice.
How does LCTX compare to LCNB fundamentally?
Lineage Cell Therapeutics, Inc. has ROE of -142.6% vs LCNB CORP's 8.4%. Net margins are -436.5% vs 22.5% respectively.
Which stock pays higher dividends, LCTX or LCNB?
LCTX has a dividend yield of N/A or no dividend while LCNB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LCTX or LCNB for long term?
For long-term investing, consider that LCTX has SELL rating with 88% confidence, while LCNB has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LCTX vs LCNB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LCTX vs LCNB, the AI consensus favors LCTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.